Roche Holding Ltd. (ROG) Given a CHF 300 Price Target by Credit Suisse Group Analysts

Roche Holding Ltd. (VTX:ROG) has been assigned a CHF 300 price target by research analysts at Credit Suisse Group in a research note issued on Monday. The firm currently has a “buy” rating on the healthcare company’s stock.

ROG has been the topic of a number of other reports. HSBC Holdings plc set a CHF 215 price target on shares of Roche Holding and gave the company a “sell” rating in a report on Tuesday, July 11th. Jefferies Group LLC set a CHF 305 price target on shares of Roche Holding and gave the company a “buy” rating in a report on Monday, May 29th. Goldman Sachs Group, Inc. (The) set a CHF 335 price target on shares of Roche Holding and gave the company a “buy” rating in a report on Friday, May 26th. Kepler Capital Markets set a CHF 231 price target on shares of Roche Holding and gave the company a “neutral” rating in a report on Tuesday, June 6th. Finally, Deutsche Bank AG set a CHF 273 price target on shares of Roche Holding and gave the company a “buy” rating in a report on Tuesday, June 27th. One equities research analyst has rated the stock with a sell rating, seven have issued a hold rating and eight have issued a buy rating to the stock. Roche Holding has a consensus rating of “Hold” and an average price target of CHF 268.20.

Roche Holding (VTX:ROG) opened at 242.30 on Monday. The stock has a market capitalization of CHK 206.75 billion and a PE ratio of 21.51. Roche Holding has a one year low of CHK 218.30 and a one year high of CHK 273.00. The firm has a 50-day moving average of CHK 243.47 and a 200 day moving average of CHK 252.54.

ILLEGAL ACTIVITY NOTICE: “Roche Holding Ltd. (ROG) Given a CHF 300 Price Target by Credit Suisse Group Analysts” was first published by Markets Daily and is the property of of Markets Daily. If you are viewing this article on another site, it was illegally stolen and reposted in violation of US & international copyright laws. The legal version of this article can be viewed at https://www.themarketsdaily.com/2017/09/13/roche-holding-ltd-rog-given-a-chf-300-price-target-by-credit-suisse-group-analysts.html.

About Roche Holding

Roche Holding AG (Roche) is a research-based healthcare company. The Company’s operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics.

Analyst Recommendations for Roche Holding (VTX:ROG)

Receive News & Ratings for Roche Holding Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roche Holding Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply